TBPH

Theravance Biopharma Inc

Price:

8.48

USD

Volume:

391,117.00

Cayman Islands | Pharmaceuticals

-371.43 %

Upside

As of 2024-06-19, the Fair Value of Theravance Biopharma Inc (TBPH) is -23.02 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.48 USD, the upside of Theravance Biopharma Inc is -371.43%.

Note: valuation result may not be accurate due to the company's negative EPS.

8.48 USD

Stock Price

-23.02 USD

Fair Price

Peter Lynch's formula is:

TBPH Fair Value

= Earnings Growth Rate x TTM EPS
TBPH Fair Value

= 25.00 x -0.92
TBPH Fair Value

= -23.02
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | -236.50 | -278.00 | -199.40 | 872.10 | -55.19 | 20.60 |

YoY growth | -9.74% | -17.55% | 28.27% | 537.36% | -106.33% | 86.40% |

Market Cap (mil) | 412.38 |

P/E | |

Forward P/E |

EPS | -0.92 |

Avg earnings growth rate | 86.40% |

TTM earnings | -44.77 |